arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Hims & Hers Health, Inc.

HIMS

$31.60 ▲ +1.94 (+6.54%) at close

8 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

Hims & Hers Health, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $7.1B

Dividend Yield —

Revenue Growth 59.0% ↘

Op. Margin 4.5% ↗

ROIC 20.2% ↘

FCF / Share $1.33 ↗

Trailing P/E 55.4x

Price / Book 13.1x

FCF Yield 4.2%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.35B

↑ +59.0% —

Net Income Profit after all expenses

$128.37M

↑ +1.8% —

Operating Margin Operating profit as % of sales

4.5%

↑ +7.3% 41th

FCF / Share Free cash flow per share

$1.33

↑ +14.7% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	59.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1080%)	69.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1286%)	65.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1210%)	93.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1776%)	82.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1555%)	80.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1504%)	—	—
EPS Growth YoY (%)	-1.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	65.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	44.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-13.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	75.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	1.8% Caution ↓ Caution Declining Year-over-year change in net income	N/M	64.1% Excellent ↑ Excellent Improving Year-over-year change in net income	39.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-494.3% Weak Weak Year-over-year change in net income	74.9% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	14.7% Fair ↓ Fair Declining Year-over-year change in free cash flow	231.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	N/M	29.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-162.7% Weak Weak Year-over-year change in free cash flow	96.7% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	64.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	75.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	80.3% Excellent Excellent Compound annual revenue growth over 3 years	85.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	73.6% Excellent Excellent Compound annual revenue growth over 5 years	78.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	4.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-63%)	4.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-65%)	-3.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-128%)	-13.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-209%)	-42.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-453%)	-10.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-185%)	-90.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-851%)	—
Effective Tax Rate (%) (%)	-3.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-75.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-9.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	5.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-32%)	8.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+7%)	-2.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-134%)	-12.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-256%)	-39.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-595%)	-12.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-252%)	-87.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1191%)	—
FCF Margin (%) (%)	12.8% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	17.0% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	8.4% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-12.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-1.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-90.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	2.34x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.99x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-3.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	20.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	22.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.4% Good Good Return earned on debt + equity capital invested Optimal: > 10%	53.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	4.9% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	8.7% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	-6.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-12.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	23.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+58%)	26.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+76%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-32.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-314%)	12.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	51.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+244%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	—	-1514.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	-201.66x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-228.62M	$-220.58M	$-96.66M	$-46.77M	$-71.78M	$-27.34M	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$10.44	$6.84	$4.17	$2.58	$1.46	$4.21	$2.38	—
Basic EPS, GAAP (USD)	$0.57	$0.58	$-0.11	$-0.32	$-0.58	$-0.51	$-2.07	—
Free Cash Flow per Share (USD)	$1.33	$1.16	$0.35	$-0.13	$-0.18	$-0.07	$-2.15	—
Book Value per Share (USD)	$2.40	$2.21	$1.64	$1.52	$1.79	$-4.15	$-4.02	—
Tangible Book Value per Share (USD)	$0.30	$1.48	$1.02	$0.88	$1.06	$-4.16	$-4.02	—
Basic Weighted Avg Shares (shares)	224.96M	215.94M	209.34M	204.52M	186.78M	35.35M	34.76M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$363.21M	$174.46M	$176.59M	$168.65M	$190.68M	$97.86M	—	—
Total Equity (USD)	$540.93M	$476.72M	$344.03M	$311.74M	$334.62M	$-146.87M	$-139.79M	$-71.36M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$2.35B	$1.48B	$872.00M	$526.92M	$271.88M	$148.76M	$82.56M	—
Depreciation Expense (USD)	$54.50M	$17.09M	$9.52M	$7.47M	$4.08M	$1.06M	$260.00K	—
Net Income, GAAP (USD)	$128.37M	$126.04M	$-23.55M	$-65.68M	$-107.66M	$-18.11M	$-72.06M	—
Operating Cash Flow (USD)	$300.01M	$251.08M	$73.48M	$-26.53M	$-34.41M	$-2.48M	$-74.87M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters

Hims & Hers Health, Inc.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HIMS with peers